Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases
Head & Neck, 07/16/2012
Turri–Zanoni M et al. – This molecular fingerprint strongly argues against the clinical efficacy of BRAF–inhibitors, but could candidate primary sinonasal mucosal melanomas to therapeutic strategies targeting RAS and KIT mutations or inhibiting PI3K–Akt–mTOR pathway.



